PSMA PET/CT can potentially reduce need for pre-imaging biopsy in frail patients Dr. Kamal Kant Kohli16 Aug 2023 8:00 PM ISTIsrael: A recent study published in The Journal of Nuclear Medicine, has shown how imaging with prostate-specific membrane antigen (PSMA) PET/CT can...
Outdoor air pollution may increase non-lung cancer risk in older adults Dr. Kamal Kant Kohli16 Aug 2023 3:30 AM ISTChronic exposure to fine particulate air pollutants (PM2.5) and nitrogen dioxide (NO2) may increase non-lung cancer risk in older adults, according to...
FDA approves niraparib regimen for BRCA-mutated metastatic castration-resistant prostate cancer Dr. Kamal Kant Kohli12 Aug 2023 10:15 AM ISTThe Food and Drug Administration has approved the fixed dose combination of niraparib and abiraterone acetate (Akeega, Janssen Biotech, Inc.), with...
Zydus Lifesciences gets CDSCO panel nod to manufacture, market Relugolix Tablets Dr. Divya Colin29 July 2023 6:00 PM ISTNew Delhi: Noting an unmet medical need in the country, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Medical Bulletin 13/July/2023 Isra Zaman13 July 2023 3:15 PM ISTHere are the top medical news for the day:Advancements in treating chemotherapy-resistant prostate cancerResearchers reporting in ACS Central Science...
Advancements in treating chemotherapy-resistant prostate cancer Isra Zaman13 July 2023 9:00 AM ISTResearchers reporting in ACS Central Science have developed the first therapy of its kind that disrupts prostate cancer cells'metabolism and releases...
Cardiorespiratory fitness prevents risk and death due to colon, lung and prostate cancer in MEN Aditi5 July 2023 8:00 PM ISTAn Original Investigation on Nutrition, Obesity, and Exercise published on June 29, 2023, in JAMA Network Open by lead author Dr Elin and colleagues...
Medical Bulletin 03/July/2023 Isra Zaman3 July 2023 2:52 PM ISTHere are the top medical news for the day: Researchers identify unique cell receptor, potential for new therapiesResearchers from the University of...
AI Unlocks Prostate Cancer Treatment Benefits Isra Zaman3 July 2023 9:15 AM ISTData from a new study published in NEJM Evidence shows promise for personalized use of short-term ADT in men with predominantly intermediate-risk...
Second-generation antiandrogens may increase cognitive decline, fatigue and falls in patients with prostate cancer Aditi28 Jun 2023 8:00 PM ISTAccording to an Original Investigation published in JAMA Oncology, researchers have concluded that prostate cancer patients treated with...
FDA approves novel prostate cancer therapy Dr. Kamal Kant Kohli24 Jun 2023 9:45 AM ISTThe US food and drug administration has approved new treatment combining two cancer drugs, enzalutamide and talazoparib for treatment of prostate...
Pfizer gets USFDA approval for Talzenna, Xtandi combo for prostate cancer treatment Ruchika Sharma21 Jun 2023 12:30 PM ISTTALZENNA (talazoparib) is an oral inhibitor of poly ADP-ribose polymerase (PARP), which plays a role in DNA damage repair.
